Increased variability [GxP / QC / QA]

posted by Ohlbe – France, 2021-09-17 19:56 (1343 d 20:26 ago) – Posting: # 22585
Views: 11,234

Hi Helmut,

❝ The CVs calculated from the confidence intervals in both ‘parts’ are much lower than the ones in the ‘full’ study. Or the other way ’round: If we pool the CVs of the ‘parts’ we could expect values which are lower than the ‘observed’ (tee-hee!) ones.


Yep. The effect on the MSE is clearly visible on Figure 4 of the paper linked by ElMaestro.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,681 registered users;
39 visitors (0 registered, 39 guests [including 18 identified bots]).
Forum time: 16:22 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5